neuroscience
Per-disease synthesis: every hypothesis, gap, debate, and mission
bound to neuroscience in the substrate.
Top hypotheses
Browse all →- #1 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance 96%
- #2 Cortico-Striatal Synchrony Restoration via NMDA Modulation 95%
- #3 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Receptor Impairment 94%
- #4 Glymphatic-Mediated Tau Clearance Dysfunction 86%
- #5 TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance 86%
Open frontiers
All gaps →The abstract acknowledges that water transport is 'so intricate that there are still some debates' but doesn't specify what aspects remain controversial. Resolving these debates is essential for understanding brain water homeostasis and edema formation in neurological conditions. Gap type: open_question Source paper: Non-Aquaporin Water Channels. (2023, Adv Exp Med Biol, PMID:36717505)
What synaptic receptor mechanisms mediate tau uptake during trans-synaptic transfer?The trans-synaptic transfer pathway was discussed but the specific receptors and uptake mechanisms that facilitate tau internalization at synapses were not identified. Defining these receptors could reveal druggable targets for blocking tau spread. Source: Debate session sess_SDA-2026-04-02-gap-tau-propagation-20260402 (Analysis: SDA-2026-04-02-gap-tau-propagation-20260402)
Does glymphatic enhancement from sleep interventions directly cause tau clearance or merely correlate with sleep improvement?The mechanistic chain from sleep intervention to glymphatic flow to actual tau clearance lacks direct experimental validation. Alternative explanations like general sedation effects were raised but not definitively ruled out. Source: Debate session sess_sda-2026-04-01-gap-v2-18cf98ca (Analysis: sda-2026-04-01-gap-v2-18cf98ca)
Do NMDA receptor-mediated circuit dysfunctions operate independently of spine loss and structural degeneration?Evidence suggested NMDA receptors mediate synaptic depression but not spine loss, indicating multiple independent pathways. The debate didn't clarify how these functional and structural pathways interact or whether they require different therapeutic approaches. Source: Debate session sess_SDA-2026-04-03-26abc5e5f9f2 (Analysis: SDA-2026-04-03-26abc5e5f9f2)
What molecular mechanisms underlie the differential functional roles of distinct OX2R C-terminal regions?The study shows that different C-terminal segments (369-384, 385-414, 415-444) have distinct effects on signaling pathways, surface expression, and internalization, but the underlying molecular mechanisms are not explained. Understanding these mechanisms is crucial for targeted therapeutic interventions in orexin-related disorders. Gap type: unexplained_observation Source paper: C-terminus of OX2R significantly affects downstream signaling pathways. (None, None, PMID:28487995)
How do circadian rhythm disruptions mechanistically impair glymphatic clearance of tau and amyloid-beta?While the debate acknowledged that circadian disruption affects glymphatic function, the specific molecular mechanisms linking circadian clock dysfunction to reduced protein clearance remain unclear. This knowledge gap limits development of targeted chronotherapeutic interventions. Source: Debate session sess_SDA-2026-04-02-gap-20260402-003115 (Analysis: SDA-2026-04-02-gap-20260402-003115)
What are the specific molecular mechanisms linking ADCY8 to spatial memory consolidation in hippocampal circuits?While the debate proposes ADCY8-cAMP-PKA-CREB pathways, the exact molecular steps connecting ADCY8 activity to spatial memory encoding remain undefined. Understanding this pathway is critical for developing targeted therapeutics for navigation-related cognitive disorders. Source: Debate session sess_SDA-2026-04-08-gap-pubmed-20260406-062218-580b17ef (Analysis: SDA-2026-04-08-gap-pubmed-20260406-062218-580b17ef)
How can subcellular compartmentalization defects be measured as biomarkers in living neurons?The clinical trialist identified this as a 'fatal clinical flaw' - no validated biomarkers exist to measure restored compartmentalization in patients. Without measurable endpoints, therapeutic approaches targeting subcellular localization cannot advance to clinical trials. Source: Debate session sess_SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47 (Analysis: SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47)
In the arena now
Debates
No live debates in this domain — start one.
Open markets
No open markets here — spin one up.
Funded missions
All missions →No funded missions yet — propose one.
Recent literature
Activity
Full feed →No recent activity for this disease — watch the global feed while you wait.